Patent Assignment
Reel/Frame 053927/0969
Assignment of Assignor's Interest
Recorded: 2020-09-30
Pages: 20
Assignor
GILEAD CONNECTICUT, INC.
Executed: 2020-09-23
Assignee
KRONOS BIO, INC.
1300 SO. EL CAMINO REAL, SUITE 300, SAN MATEO, CALIFORNIA, 94402
Covered Properties
(44)
Certain Substituted Amides, Method of Making, and Method of Use Thereof
PCT:
PCT/US2009/000919 ↗
Imidazopyrazine Syk Inhibitors
PCT:
PCT/US2009/006445 ↗
Imidazopyrazine Syk Inhibitors
PCT:
PCT/US2009/006446 ↗
Imidazopyrazine Syk Inhibitors
PCT:
PCT/US2013/046034 ↗
Certain Substituted Amides, Method of Making, and Method of Use Thereof
Application:
12/370,103 →
Publication:
US 2009/0221612
Imidazopyrazine Syk Inhibitors
Imidazopyrazine Syk Inhibitors
Imidazopyrazine Syk Inhibitors
6-(1H-Indazol-6-Yl)-N-[4-(Morpholin-4-Yl)Phenyl]Imidazo-[1,2-A]Pyrazin-8-Amine, or a Pharmaceutically Acceptable Salt Thereof, as a Syk Inhibitor
Imidazopyridines Syk Inhibitors
Application:
13/609,068 →
Publication:
US 2014/0148430
Imidazopyridines Syk Inhibitors
N-[6-(1H-Indazol-6-Yl)Imidazo[1,2-A]Pyridin-8-Yl]-6-(Morpholin-4-Yl)Pyridazin-3-Amine, or a Pharmaceutically Acceptable Salt Thereof, as a Syk Inhibitor
Imidazopyrazine Syk Inhibitors
6-(1H-Indazol-6-Yl)-N-{4-[2-Methyl-1-(Morpholin-4-Yl)Propan-2-Yl]Phenyl}Imidazo[1,2-A]Pyrazin-8-Amine, or a Pharmaceutically Acceptable Salt Thereof, as a Syk Inhibitor
Imidazopyrazine Syk Inhibitors
Imidazopyrazine Syk Inhibitors
Application:
13/901,523 →
Publication:
US 2013/0267496
Imidazopyrazine Syk Inhibitors
Application:
13/918,848 →
Publication:
US 2013/0338142
6-(1H-Indazol-6-Yl)-N-(4-Morpholinophenyl)Imidazo[1,2-A]Pyrazin-8-Amine for Treating Leukemia or Lymphoma
6-(2,3-DIHYDRO-1H-PYRIDO-[2,3-b][1,4]OXAZIN-7-YL)-N-(4-MORPHOLINOPHENYL)IMIDAZO[1,2-a]PYRAZIN-8-AMINE AS A SPLEEN TYROSINE KINASE INHIBITOR
Formulation of Syk Inhibitors
Polymorph of Syk Inhibitors
SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS SYK INHIBITORS
6-(BENZO[d]THIAZOL-5-YL)-N-(3,4-DIMETHOXYPHENYL)IMIDAZO[1,2-a]PYRAZIN-8-AMINE
Formulation of Syk Inhibitors
Polymorph of Syk Inhibitors
Application:
14/907,767 →
Publication:
US 2016/0168155
Formulation of Syk Inhibitors
Imidazopyridines Syk Inhibitors
SUBSTITUTED IMIDAZO[1,2-a]PYRAZINES AS SYK INHIBITORS
Polymorph of Syk Inhibitors
Application:
15/484,844 →
Publication:
US 2017/0217967
Synthesis of 6-(1H-Indazol-6-Yl)-N-(4-Morpholinophenyl)Imidazo[1,2-A]-Pyrazin-8-Amine
Application:
15/719,399 →
Publication:
US 2018/0086769
Polymorph of Syk Inhibitors
Imidazopyridines Syk Inhibitors
Certain Substituted Amides, Method of Making, and Method of Use Thereof
Application:
61/028,463 →
Imidazopyrazine Syk Inhibitors
Application:
61/120,587 →
Imidazopyrazine Syk Inhibitors
Application:
61/120,590 →
Imidazopyrazine Syk Inhibitors
Application:
61/140,514 →
Imidazopyrazine Syk Inhibitors
Application:
61/140,535 →
Imidazopyrazine Syk Inhibitors
Application:
61/240,979 →
Imidazopyrazine Syk Inhibitors
Application:
61/240,983 →
Imidazopyridines Syk Inhibitors
Application:
61/312,771 →
Imidazopyridines Syk Inhibitors
Application:
61/313,223 →
Imidazopyrazine Syk Inhibitors
Application:
61/659,936 →
Polymorph of Syk Inhibitors
Application:
61/860,197 →
Formulation of Syk Inhibitors
Application:
61/860,198 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 13, 2009
From: MITCHELL, SCOTT A.; CURRIE, KEVIN S.; BLOMGREN, PETER A.; ARMISTEAD, DAVID M.
To: CGI PHARMACEUTICALS, INC.
Reel/Frame 022676/0987 →
Assignment of Assignor's Interest
Feb 10, 2010
From: MITCHELL, SCOTT A.; CURRIE, KEVIN S.; BLOMGREN, PETER A.; KROPF, JEFFREY E.
To: CGI PHARMACEUTICALS, INC.
Reel/Frame 023922/0796 →
Assignment of Assignor's Interest
Mar 8, 2010
From: MITCHELL, SCOTT A.; CURRIE, KEVIN S.; BLOMGREN, PETER A.; KROPF, JEFFREY E.
To: CGI PHARMACEUTICALS, INC.
Reel/Frame 024047/0122 →
Assignment of Assignor's Interest
May 21, 2010
From: BARBOSA, ANTONIO J, JR.; ZHAO, ZHONGDONG
To: CGI PHARAMACEUTICALS, INC.
Reel/Frame 024425/0223 →
Agreement and Plan of Merger
Oct 4, 2010
From: CGI PHARMACEUTICALS, INC.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 025084/0218 →
Assignment of Assignor's Interest
Jul 27, 2011
From: ARMISTEAD, DAVID M.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 026655/0912 →
Assignment of Assignor's Interest
Apr 6, 2012
From: MITCHELL, SCOTT A.; CURRIE, KEVIN S.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 028008/0234 →
Assignment of Assignor's Interest
Aug 21, 2012
From: MITRA, SOUMYA
To: GILEAD CONNECTICUT, INC.
Reel/Frame 028820/0282 →
Assignment of Assignor's Interest
Nov 21, 2012
From: BLOMGREN, PETER A.; CURRIE, KEVIN S.; KROPF, JEFFREY E.; LEE, SEUNG H.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 029339/0362 →
Assignment of Assignor's Interest
Apr 22, 2013
From: BLOMGREN, PETER A.; CURRIE, KEVIN S.; KROPF, JEFFREY E.; LEE, SEUNG H.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 030262/0982 →
Corrective Assignment to Correct the City Name in the Address of the Assignee from Forster City to Foster City Previously Recorded on Reel 028008 Frame 0234. Assignor(S) Hereby Confirms the Assignee.
Apr 24, 2013
From: MITCHELL, SCOTT A.; CURRIE, KEVIN S.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 030292/0960 →
Merger
Aug 15, 2013
From: CGI PHARMACEUTICALS, INC.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 031022/0241 →
Assignment of Assignor's Interest
Aug 15, 2013
From: MITCHELL, SCOTT A.; CURRIE, KEVIN S.; BLOMGREN, PETER A.; ARMISTEAD, DAVID M.
To: CGI PHARMACEUTICALS, INC.
Reel/Frame 031022/0213 →
Assignment of Assignor's Interest
Aug 21, 2013
From: BLOMGREN, PETER A.; CURRIE, KEVIN S.; KROPF, JEFFREY E.; LEE, SEUNG H.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 031049/0805 →
Assignment of Assignor's Interest
Aug 21, 2013
From: MITCHELL, SCOTT A.; CURRIE, KEVIN S.; BLOMGREN, PETER A.; KROPF, JEFFREY E.
To: CGI PHARMACEUTICALS, INC.
Reel/Frame 031057/0144 →
Merger
Aug 21, 2013
From: CGI PHARMACEUTICALS, INC.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 031057/0188 →
Merger
Sep 16, 2013
From: CGI PHARMACEUTICALS, INC.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 031215/0792 →
Assignment of Assignor's Interest
Sep 16, 2013
From: MITCHELL, SCOTT A.; CURRIE, KEVIN S.; BLOMGREN, PETER A.; KROPF, JEFFREY E.
To: CGI PHARMACEUTICALS, INC.
Reel/Frame 031215/0767 →
Merger
Jan 15, 2014
From: CGI PHARMACEUTICALS, INC.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 031979/0074 →
Assignment of Assignor's Interest
Jan 15, 2014
From: ARMISTEAD, DAVID M.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 031979/0061 →
Assignment of Assignor's Interest
Jan 15, 2014
From: BARBOSA, ANTONIO J., JR; ZHAO, ZHONGDONG
To: CGI PHARMACEUTICALS, INC.
Reel/Frame 031979/0051 →
Assignment of Assignor's Interest
Jan 15, 2014
From: MITCHELL, SCOTT A.; CURRIE, KEVIN S.; BLOMGREN, PETER A.; KROPF, JEFFREY E.
To: CGI PHARMACEUTICALS, INC.
Reel/Frame 031979/0039 →
Assignment of Assignor's Interest
Jan 15, 2014
From: MITRA, SOUMYA
To: GILEAD CONNECTICUT, INC.
Reel/Frame 031979/0071 →
Assignment of Assignor's Interest
Mar 11, 2014
From: MITRA, SOUMYA
To: GILEAD CONNECTICUT, INC.
Reel/Frame 032409/0691 →
Assignment of Assignor's Interest
Mar 11, 2014
From: ARMISTEAD, DAVID M.
To: GILEAD CONNECTICUT, INC.
Reel/Frame 032409/0684 →